ProCE Banner Activity

Atopic Dermatitis Treatment Made Simple: A Clinician's Pocket Guide to Biologics for Moderate to Severe Cases

PDF

This downloadable decision support pocket guide is designed for health care providers treating moderate to severe atopic dermatitis. It provides essential information on patient candidacy and treatment advancements with biologic therapies, synthesizing key data and guidelines into an easy-to-reference format. Equip yourself with this practical resource to enhance your clinical practice and optimize care for patients with moderate to severe atopic dermatitis.

Released: October 24, 2024

Expiration: October 23, 2025

Share

Faculty

Jonathan Silverberg

Jonathan Silverberg, MD, PhD, MPH

Professor
Director of Clinical Research
Director of Patch Testing
George Washington University School of Medicine and Health Sciences
Washington, DC

Provided by

Provided by Partners for Advancing Clinical Education (PACE) in partnership with the Dermatology Education Foundation Dermalorian™ Webinar Series

ProCE Banner

Supporters

This activity is supported by an educational grant from Lilly.

Lilly

Partners

Dermatology Education Foundation Dermalorian™ Webinar Series

ProCE Banner

Disclosure

Primary Author

Jonathan Silverberg, MD, PhD, MPH

Professor
Director of Clinical Research
Director of Patch Testing
George Washington University School of Medicine and Health Sciences
Washington, DC

Jonathan Silverberg, MD, PhD, MPH: consultant/advisor/speaker: AbbVie, Alamar, Aldena, Amgen, AOBiome, Apollo, Arcutis, Arena, Asana, Aslan, Attovia, BiomX, Biosion, Bodewell, Boehringer Ingelheim, Bristol Myers Squibb, Cara, Castle Biosciences, Celgene, Connect Biopharma, CorEvitas, Dermavant, FIDE, Galderma, GlaxoSmithKline, Incyte, Inmagene, Invea, Kiniksa, Leo Pharma, Lilly, Merck, MyOr Diagnostics, Nektar, Novartis, Optum, Pfizer, RAPT, Recludix, Regeneron, Sandoz, Sanofi/Genzyme, Shaperon, Target RWE, Teva, Union.